Overview

Intravenous Tirofiban Versus Alteplase Before Mechanical Thrombectomy in Stroke

Status:
Not yet recruiting
Trial end date:
2027-06-01
Target enrollment:
Participant gender:
Summary
In patients with acute ischemic stroke secondary to large vessel occlusion, the role of intravenous adjunctive medications, such as tirofiban, or alteplase before endovascular thrombectomy has not been well investigated. This trial aim to evaluate the efficacy and safety of intravenous tirofiban versus alteplase for acute ischemic stroke patients with large vessel occlusion piror to endovascular thrombectomy.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Xinqiao Hospital of Chongqing
Collaborator:
Zhejiang University
Treatments:
Tirofiban
Tissue Plasminogen Activator